Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000BF3
CNY
20.90
0.05 (0.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.

Why is Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.37%
  • Poor long term growth as Net Sales has grown by an annual rate of 1.15% and Operating profit at 30.52% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.
85.12%
3.70
43.70%
China Shanghai Composite
15.17%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
1.15%
EBIT Growth (5y)
30.52%
EBIT to Interest (avg)
-3.09
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.87
Sales to Capital Employed (avg)
1.20
Tax Ratio
20.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.37%
ROE (avg)
12.29%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
47
Industry P/E
Price to Book Value
35.60
EV to EBIT
41.26
EV to EBITDA
27.56
EV to Capital Employed
12.71
EV to Sales
9.09
PEG Ratio
0.20
Dividend Yield
NA
ROCE (Latest)
30.80%
ROE (Latest)
76.01%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY -28.55 MM

NET SALES(9M)

At CNY 158.94 MM has Grown at 27.89%

NET PROFIT(HY)

At CNY 9.11 MM has Grown at 51.22%

INVENTORY TURNOVER RATIO(HY)

Highest at 3.16 times

RAW MATERIAL COST(Y)

Fallen by -7.82% (YoY

-15What is not working for the Company
PRE-TAX PROFIT(Q)

At CNY 2.88 MM has Fallen at -80.17%

NET SALES(Q)

At CNY 55.34 MM has Fallen at -15.3%

INTEREST COVERAGE RATIO(Q)

Lowest at 292.48

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.27 times

OPERATING PROFIT(Q)

Lowest at CNY 5.25 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.48 %

NET PROFIT(Q)

Lowest at CNY 3.96 MM

EPS(Q)

Lowest at CNY 0.03

Here's what is working for Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.

Operating Cash Flow
Highest at CNY -28.55 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio
Highest at 3.16 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -7.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.

Pre-Tax Profit
At CNY 2.88 MM has Fallen at -80.17%
over average net sales of the previous four periods of CNY 14.54 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 3.96 MM has Fallen at -64.36%
over average net sales of the previous four periods of CNY 11.11 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales
At CNY 55.34 MM has Fallen at -15.3%
over average net sales of the previous four periods of CNY 65.34 MM
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio
Lowest at 292.48
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at CNY 5.25 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 9.48 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit
Lowest at CNY 3.96 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS
Lowest at CNY 0.03
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio
Lowest at 2.27 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio